ACHIEVE LIFE SCIENCES, INC. 10-K, filed Mar 10, 2022: IDEA: XBRL DOCUMENT
Common Stock - Computation of Basic and Diluted Net Loss Attributable to Common Shareholders Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Sep. 30, 2020 |
Jun. 30, 2020 |
Mar. 31, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Numerator | |||||||||||
| Net loss | $ (7,151) | $ (6,691) | $ (11,311) | $ (7,999) | $ (4,724) | $ (3,764) | $ (2,922) | $ (3,320) | $ (33,152) | $ (14,730) | $ (16,395) |
| Denominator | |||||||||||
| Weighted average number of common shares outstanding | 8,119,836 | 2,718,909 | 412,320 | ||||||||
| Basic and diluted net loss per common share | $ (0.76) | $ (0.71) | $ (1.53) | $ (1.30) | $ (1.11) | $ (1.14) | $ (1.68) | $ (2.15) | $ (4.08) | $ (5.42) | $ (39.76) |